Dementia and other chronic diseases in older adults in Havana and Matanzas: the 10/66 study in Cuba.

INTRODUCTION Chronic non-communicable diseases are the leading cause of death worldwide, except in Sub-Saharan Africa. Nonetheless, one of these conditions, dementia, is the major contributor to disability-adjusted life years in people aged ≥60 years. Few epidemiological studies exist of the prevalence and impact of dementia and selected chronic diseases in older adults in Latin America. OBJECTIVE Describe prevalence of dementia, other chronic vascular diseases and cardiovascular risk factors, as well as resulting disabilities and care needs generated in adults aged ≥65 years in Havana City and Matanzas provinces, Cuba. METHODS The 10/66 study is a prospective longitudinal study involving a cohort of 3015 adults aged ≥65 years in municipalities of Havana City and Matanzas provinces, divided into two phases: a cross-sectional door-to-door study conducted in 2003-2006, and a follow-up and assessment phase in 2007-2010. This article reports findings from the first phase. Hypertension diagnosis was based on criteria from the International Society for Hypertension; diabetes mellitus on American Diabetes Association criteria; stroke according to WHO definitions; and dementia according to criteria of the American Psychiatric Society's Diagnostic and Statistical Manual of Mental Disorders DSM-IV and the 10/66 International Dementia Research Group. Ischemic heart disease was defined by self-report of previous physician diagnosis. Study variables included age, sex, educational level, substance use (alcohol, tobacco) and dietary habits. A structured physical and neurological exam, including blood pressure measurement, was performed on all participants. Laboratory tests included complete blood count, fasting blood glucose, total cholesterol and lipoprotein fractions, triglycerides and apolipoprotein E genotype. Prevalence and standardized morbidity ratios (crude and adjusted) were calculated for chronic diseases studied with 95% confidence intervals, using a Poisson regression model and indirect standardization. RESULTS The study assessed 2944 older adults (response rate 97.6%) and found high prevalence of vascular risk factors and of chronic non-communicable diseases: hypertension 73.0% (95% CI 71.4-74.7), diabetes mellitus 24.8% (95% CI 22.9-26.5), ischemic heart disease 14.1% (95% CI 12.9-15.4), dementia 10.8% (95% CI 9.7-12.0) and stroke 7.8% (95% CI 6.9-8.8). The majority of participants (85%) had more than one cardiovascular risk factor. The main cause of disability and dependency in the study population was dementia. CONCLUSION The high prevalence of chronic diseases observed in the elderly--with the consequent morbidity, disability and dependency--highlights the need for prevention, early diagnosis and risk factor control, particularly given the demographic and epidemiologic transition faced by Cuba and other developing countries.

[1]  Yichong Li,et al.  AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN CHINA: FINDINGS FROM 2010 CHINA CHRONIC DISEASE AND RISK FACTOR SURVEILLANCE , 2012, Heart.

[2]  R. Horton,et al.  Chronic diseases: global action must match global evidence , 2010, The Lancet.

[3]  A. Valhuerdi,et al.  Prevalence of stroke and associated risk factors in older adults in Havana City and Matanzas Provinces, Cuba (10/66 population-based study). , 2010, MEDICC review.

[4]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[5]  M. Prince,et al.  Measuring disability across cultures — the psychometric properties of the WHODAS II in older people from seven low‐ and middle‐income countries. The 10/66 Dementia Research Group population‐based survey , 2010, International journal of methods in psychiatric research.

[6]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[7]  M. Guerra,et al.  Prevalence of Dementia and Alzheimer's Disease in a Havana Municipality: A Community-Based Study among Elderly Residents. , 2009, MEDICC review.

[8]  A. Valhuerdi,et al.  The Prevalence, Correlates and Impact of Dementia in Cuba , 2008, Neuroepidemiology.

[9]  B. Longo-Mbenza,et al.  Screen detection and the WHO STEPwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[10]  Shuran Li,et al.  Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey , 2008, The Lancet.

[11]  R. Stewart,et al.  The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study , 2008, BMC public health.

[12]  S. Yusuf,et al.  Global burden of cardiovascular disease , 2007, Heart.

[13]  Donna Bergen Neurological Disorders: Public Health Challenges , 2007 .

[14]  R. Uwakwe,et al.  The protocols for the 10/66 dementia research group population-based research programme , 2007, BMC public health.

[15]  Margaret Carroll,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control in Older U.S. Adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004 , 2007, Journal of the American Geriatrics Society.

[16]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[17]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[18]  V. Fuster,et al.  MDGs: chronic diseases are not on the agenda , 2005, The Lancet.

[19]  Colin Mathers,et al.  Preventing chronic diseases: how many lives can we save? , 2005, The Lancet.

[20]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[21]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[22]  Gustavo Saposnik,et al.  Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. , 2003, Stroke.

[23]  Jing Chen,et al.  Geographic variations in the prevalence, awareness, treatment and control of hypertension in China , 2003, Journal of hypertension.

[24]  M. Prince,et al.  Dementia diagnosis in developing countries: a cross-cultural validation study , 2003, The Lancet.

[25]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[26]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[27]  J. Copeland,et al.  Diagnosis of dementia from the history and aetiology schedule , 2001, International journal of geriatric psychiatry.

[28]  A. King,et al.  The question of familial meningiomas and schwannomas: , 2000, Neurology.

[29]  Á. Pérez-Sempere [Cerebrovascular morbidity in Spain: incidence and prevalence]. , 1999, Revista de neurologia.

[30]  Shekhar Saxena,et al.  On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population , 1999 .

[31]  K. Davis,et al.  The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease , 1997, International journal of geriatric psychiatry.

[32]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International Psychogeriatrics.

[33]  G. Ratcliff,et al.  Cognitive Test Performance in a Community-Based Nondemented Elderly Sample in Rural India: The Indo-U.S. Cross-National Dementia Epidemiology Study , 1996, International Psychogeriatrics.

[34]  A. Verghese,et al.  Harrison's Principles of Internal Medicine , 1994 .

[35]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[36]  Robert A. Zimmerman,et al.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. , 1990, Stroke.

[37]  J. Copeland,et al.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT , 1986, Psychological Medicine.

[38]  C. Gilleard,et al.  Emotional Distress amongst the Supporters of the Elderly Mentally Infirm , 1984, British Journal of Psychiatry.

[39]  A. J. Akhtar,et al.  Neurological disorders in the elderly at home. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[40]  Gretchen A. Stevens,et al.  Chronic Diseases: Chronic Diseases and Development 5 Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries , 2010 .

[41]  C. Ferri,et al.  World Alzheimer Report 2009 , 2009 .

[42]  Alejandro Macchia,et al.  CARMELA: assessment of cardiovascular risk in seven Latin American cities. , 2008, The American journal of medicine.

[43]  V. Reef,et al.  Chapter 8 – Disorders of the Cardiovascular System , 2004 .

[44]  R. Hu Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[45]  A. Hofman,et al.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[46]  S. Hatano,et al.  Experience from a multicentre stroke register: a preliminary report. , 1976, Bulletin of the World Health Organization.

[47]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2022 .